Form 4: Incyte Director Acquires Shares, Exercises Options
Insider Transaction Report
Incyte Corp. Director Paul J. Clancy acquired 1,642 shares of common stock and exercised a stock option for 6,111 shares.
Summary
- Paul J. Clancy, a Director at Incyte Corp., acquired 1,642 shares of common stock on June 8, 2026.
- The acquisition of these shares was part of an award of restricted stock units (RSUs) that vest on the first anniversary of the grant date, the next annual meeting, or a change of control.
- Clancy also exercised a non-qualified stock option to purchase 6,111 shares of common stock at an exercise price of $100.64 per share.
- This stock option vests in full on the first anniversary of the grant date, the next annual meeting, or upon a change of control.
- Following these transactions, Clancy beneficially owns 25,383 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While insider transactions can be positive indicators, the details provided are standard for compensation awards and option exercises, without immediate strong signals of significant positive or negative future performance.
Positives
- Director acquisition of shares indicates confidence in the company's future.
- Exercise of stock options suggests potential for increased shareholder value if the stock price is above the exercise price.
Risks
- The vesting conditions for RSUs and stock options (anniversary, annual meeting, change of control) could lead to future sales of stock.
- The exercise price of the stock option ($100.64) implies a significant increase in stock value is needed for the option to be profitable.
Future Outlook
The filing does not contain forward-looking statements or guidance. The details provided relate to past transactions and ownership.
Industry Context
StockSavvy.ai notes that insider transactions, such as those reported on Form 4, are closely watched by investors as they can signal management's confidence in the company's prospects. The acquisition of shares and exercise of options by a director at Incyte Corp. could be interpreted positively, though the specific terms of the awards and vesting schedules are important considerations.
Stakeholder Impact
- Shareholders may view director stock acquisitions positively, potentially signaling confidence in the company's value.
- Employees involved in stock-based compensation plans may see these transactions as part of standard executive compensation practices.
Next Steps
- Vesting of restricted stock units on the first anniversary of the grant date, the next regular annual meeting, or upon a change of control.
- Vesting of stock option on the first anniversary of the grant date, the next regular annual meeting, or upon a change of control.
Key Dates
| Date | Description |
|---|---|
| 06/08/2026 | Transaction Date for acquisition of common stock and exercise of stock option. |
| 06/07/2036 | Expiration date for the non-qualified stock option. |
| 06/10/2026 | Date of Report Signature. |
Keywords
Incyte Corp, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Transactions, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.